Haemonetics Seeks New Blood With Surprise CEO Exit
This article was originally published in Clinica
Blood management device maker Haemonetics is looking for a permanent President and CEO to replace Brian Concannon, who has resigned from his role after six years at the helm. He will remain with the company until the end of the month. Ronald Gelbman, who has been a long-standing board member, will step in as interim CEO while the company conducts its executive search.
You may also be interested in...
Minimally invasive glaucoma surgery specialist Glaukos saw its stock leap 40% in the wake of a worldwide recall by much bigger rival Alcon of its CyPass microstent.
Roland Diggelmann will end his decade-long career at Roche Diagnostics at the end of September. The business's head of EMEA Michael Heuer will take Diggelmann's place while the search is on for his replacement.
Philips has added a new pulse oximetry platform to its patient monitoring portfolio, with the acquisition of Xhale Assurance.